Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital of Zhejiang UniversityActive in the last 2 years

Lantian Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2117-4985; OpenAlex author ID A5102873063. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2017: 1 paper · 2018: 2 papers · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper

Papers 8

  1. Combined Therapy of Chemotherapy and Radiofrequency Ablation for Pancreatic Cancer Patients With Metachronous Hepatic Metastatic Lesions After Radical Pancreat… Co-author DOI 10.1177/10732748241274559↗
  2. Sequential therapy for pancreatic cancer patients with synchronous oligo-hepatic metastatic lesions. First author DOI 10.1177/03008916221110265↗
  3. Pancreatic Cancer-Derived Exosomal miR-Let-7b-5p Stimulates Insulin Resistance in Skeletal Muscle Cells Through RNF20/STAT3/FOXO1 Axis Regulation. Co-author DOI 10.2147/dmso.s430443↗
  4. Efficacy and safety of FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer after gemcitabine-based therapy: A systematic review and meta-anal… First author DOI 10.1177/03000605221093225↗
  5. Exosomal microRNA-let-7b-5p Derived From Pancreatic Cancer Cells Possibly Promotes Insulin Resistance in C2C12 Myotube Cells by Targeting SLC6A15 Co-author DOI 10.21203/rs.3.rs-689703/v1↗
  6. Thymidylate synthase prompts metastatic progression through the dTMP associated EMT process in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.canlet.2018.01.026↗
  7. Pancreatic cancer-derived exosomes suppress the production of GIP and GLP-1 from STC-1 cells in vitro by down-regulating the PCSK1/3. Co-author DOI 10.1016/j.canlet.2018.05.027↗
  8. Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway. Co-author DOI 10.1038/s41598-017-05541-4↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wenjie Lu · 3 shared papers, 2018–2023 · strength 0.56
  2. Kezhong Tang · 2 shared papers, 2022–2023 · strength 0.49
  3. Weirong Lu · 1 shared paper, 2024 · strength 0.31
  4. Jing Wu · 1 shared paper, 2024 · strength 0.31
  5. Qiang Tang · 1 shared paper, 2023 · strength 0.26
  6. Xiawei Li · 1 shared paper, 2022 · strength 0.22
  7. Muxing Kang · 3 shared papers, 2017–2018 · strength 0.21
  8. Yulian Wu · 3 shared papers, 2017–2018 · strength 0.21
  9. Yuefeng Zhang · 2 shared papers, 2017–2018 · strength 0.14
  10. Yizhao Zhou · 2 shared papers, 2018 · strength 0.14
  11. Pengping Li · 2 shared papers, 2018 · strength 0.14
  12. Bin Juan Yang · 1 shared paper, 2018 · strength 0.07
  13. Wen Ling Zheng · 1 shared paper, 2017 · strength 0.07
  14. Wenjie Qin · 1 shared paper, 2017 · strength 0.07
  15. Qing Chen · 1 shared paper, 2018 · strength 0.07
  16. Qingqu Guo · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.